搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
2 小时
天风证券:信达生物(01801)2024年中报符合预期 维持“买入”评级
智通财经APP获悉,天风证券发布研究报告称,维持信达生物(01801)“买入”评级,考虑到公司已上市产品持续放量,多条研发管线即将进入产品收获期,将2024和2025年的收入预期分别从72.25、91.93亿元上调至79.70、102.35亿元,预计 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Announces retirement
How to help Milton victims
Inflation likely cooled again
Jobless claims surge
Files suit against accuser
US warns of solar storm
Walz on Electoral College
Top colleges hit with lawsuit
Meat, poultry items recalled
Increases heart attack risk?
Nobel Prize in literature
AZ Senate debate takeaways
Judge tosses New York law
Tesla robotaxi launch
Speaks with Netanyahu
GSK to settle 80K lawsuits
Georgia election board sued
To settle FTC charges
Idaho murder trial delayed
Rare comet in October
Ukraine meeting postponed
$273M Helene relief bill
Faces $3B in penalties
Ex-AR deputy sentenced
Mets advance to NLCS
Campaign, groups raise $1B
Approves elimination of NLI
反馈